tiprankstipranks
Vera Therapeutics, Inc. (VERA)
NASDAQ:VERA
US Market
VERA
Vera Therapeutics
RESEARCH TOOLSreports
Want to see VERA full AI Analyst Report?

Vera Therapeutics (VERA) Stock News & Sentiment

790 Followers
Analyst Reiterates Buy on Vera as Atacicept Progress and Strong Cash Position Support Unchanged $110 Price Target
Premium
Ratings
Analyst Reiterates Buy on Vera as Atacicept Progress and Strong Cash Position Support Unchanged $110 Price Target
12d ago
VERA
Vera Therapeutics: Buy Rating Reiterated on Strong Atacicept Outlook and Launch Readiness; $73 Price Target Maintained
Premium
Ratings
Vera Therapeutics: Buy Rating Reiterated on Strong Atacicept Outlook and Launch Readiness; $73 Price Target Maintained
16d ago
VERA
Maintaining the Bull Case on Vera: Atacicept’s Competitive Edge and $2.2B IgAN Peak Sales Upside
Premium
Ratings
Maintaining the Bull Case on Vera: Atacicept’s Competitive Edge and $2.2B IgAN Peak Sales Upside
3M ago
VERA
Vera Therapeutics Adds Christopher Hite to Board
Premium
Company Announcements
Vera Therapeutics Adds Christopher Hite to Board
3M ago
8K
VERA
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026
Premium
Market News
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026
3M ago
UPB
VERA
Vera Therapeutics: Strong Atacicept Phase 3 Data and Favorable Regulatory, Commercial Setup Support Buy Rating
Premium
Ratings
Vera Therapeutics: Strong Atacicept Phase 3 Data and Favorable Regulatory, Commercial Setup Support Buy Rating
3M ago
VERA
Undervalued IgAN Opportunity: Buy Rating on VERA Driven by Atacicept’s Robust ORIGIN 3 Data and Long-Term Kidney Disease Upside
Premium
Ratings
Undervalued IgAN Opportunity: Buy Rating on VERA Driven by Atacicept’s Robust ORIGIN 3 Data and Long-Term Kidney Disease Upside
3M ago
VERA
More VERA News >

VERA News on the Web

Vera Therapeutics (VERA) Receives a Buy from Evercore ISI
TipRanks News
Bullish
Vera Therapeutics price target lowered to $91 from $95 at Evercore ISI
TipRanks News
Neutral
Why Vera Therapeutics Stock Is Suddenly Sinking
TipRanks News
Neutral
Analyst Reiterates Buy on Vera as Atacicept Progress and Strong Cash Position Support Unchanged $110 Price Target
TipRanks News
Bullish
Vera Therapeutics Stock Jumps on FDA Green Light
TipRanks News
Bullish
Vera Therapeutics (VERA) Receives a Buy from Guggenheim
TipRanks News
Bullish
Wedbush Sticks to Its Hold Rating for Vera Therapeutics (VERA)
TipRanks News
Neutral
Vera Therapeutics: Buy Rating Reiterated on Strong Atacicept Outlook and Launch Readiness; $73 Price Target Maintained
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
VERA
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.75 articles
News Sentiment
This Week99%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VERA’s Media Buzz Sentiment?
2 articles about VERA were published this week. In an average week, 2.75 articles are published.
    What is VERA’s weekly average amount of articles?
    In an average week, 2.75 articles about VERA are published.
      What is VERA’s News Sentiment?
      99% of articles about VERA were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week